LABIRIAD Trademark

Trademark Overview

On Monday, January 7, 2008, a trademark application was filed for LABIRIAD with the United States Patent and Trademark Office. The USPTO has given the LABIRIAD trademark a serial number of 79050020. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Sunday, January 7, 2018. This trademark is owned by BIOALLIANCE PHARMA. The LABIRIAD trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of herpes
labiriad

General Information

Serial Number79050020
Word MarkLABIRIAD
Filing DateMonday, January 7, 2008
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateSunday, January 7, 2018
Registration Number3527824
Registration DateTuesday, November 4, 2008
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 19, 2008

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of herpes
Translation of Words in MarkThe wording "LABIRIAD" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, June 5, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameONXEO
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressFR
Party NameBIOALLIANCE PHARMA
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressFR
Party NameBIOALLIANCE PHARMA
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressFR

Trademark Events

Event DateEvent Description
Friday, August 3, 2018NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Friday, August 3, 2018DEATH OF INTERNATIONAL REGISTRATION
Friday, March 31, 2017TOTAL INVALIDATION PROCESSED BY THE IB
Friday, April 8, 2016TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Friday, April 8, 2016INVALIDATION PROCESSED
Friday, February 5, 2016TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, June 26, 2015CHANGE OF NAME/ADDRESS REC'D FROM IB
Friday, June 5, 2015CANCELLED SECTION 71
Thursday, October 30, 2014NEW REPRESENTATIVE AT IB RECEIVED
Friday, March 30, 2012CHANGE OF NAME/ADDRESS REC'D FROM IB
Saturday, March 14, 2009FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, February 19, 2009FINAL DISPOSITION NOTICE SENT TO IB
Thursday, February 19, 2009FINAL DISPOSITION PROCESSED
Thursday, February 5, 2009FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, November 4, 2008REGISTERED-PRINCIPAL REGISTER
Tuesday, August 19, 2008PUBLISHED FOR OPPOSITION
Wednesday, July 30, 2008NOTICE OF PUBLICATION
Friday, July 11, 2008LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, July 10, 2008ASSIGNED TO LIE
Thursday, July 10, 2008APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 9, 2008TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, July 9, 2008TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, July 9, 2008CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, July 9, 2008TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, April 24, 2008REFUSAL PROCESSED BY IB
Wednesday, April 9, 2008NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, April 9, 2008REFUSAL PROCESSED BY MPU
Wednesday, April 9, 2008NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, April 8, 2008NON-FINAL ACTION WRITTEN
Tuesday, April 8, 2008ASSIGNED TO EXAMINER
Friday, March 14, 2008NEW APPLICATION ENTERED IN TRAM
Thursday, March 13, 2008SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

labiriad herpes treatment preparations pharmaceutical